Table 1.
Author et al. | Study Design | Patients (n) | Age Range | Groups | Assessed Interleukin Polymorphisms | Outcome |
---|---|---|---|---|---|---|
Borilova Linhartova et al. [14] | CS/CC | 1106 patients | 30–77 years | Gp-1: Patients with periodontitis Gp-2: Patients with type-1 DM Gp-3: Patients with periodontitis and type-1 DM Gp-4: Patients with type-2 DM Gp-5: Patients with periodontitis and type-2 DM |
IL-1 gene |
|
López et al. [15] | CS/CC | 544 patients | 42–68 years | Gp-1: Patients with periodontitis Gp-2: Patients with type-2 DM Gp-3: Patients without type-2 DM and periodontitis |
IL-1 gene |
|
Kavitha et al. [16] | CC | 120 patients | NR | Gp-1: Patients with periodontitis Gp-2: Patients with type-2 DM Gp-3: Patients with periodontitis and type-2 DM Gp-4: Patients without type-2 DM and periodontitis |
IL-6 gene |
|
Deppe et al. [17] | CC | 104 patients | 48–72 years | Gp-1: Patients with type-2 DM Gp-2: Patients without type-2 DM |
IL-1 gene |
|
Cirelli et al. [18] | CS/CC | 894 patients | Gp-1: Patients with periodontitis Gp-2: Patients with periodontitis Gp-3: Patients with type-2 DM |
IL-1A, IL-1B, IL-4, IL-6 and IL-10 |
|
|
Petrovic et al. [19] | CC | Gp-1: Patients with periodontitis Gp-2: Patients with periodontitis and type-2 DM Gp-3: Patients without type-2 DM and periodontitis |
|
|||
Xiao et al. [20] | CS/CC | 492 patients | 40–87 years | Gp-1: Patients with periodontitis Gp-2: Patients with type-2 DM Gp-3: Patients with periodontitis and type-2 DM Gp-4: Patients without type-2 DM and periodontitis |
IL-6 gene |
|
Struch et al. [22] | CS/CC | 1515 patients | 40–60 years | Gp-1: Patients with type-2 DM Gp-2: Patients without type-2 DM |
IL-1A/1B haplotype |
|
CS: cross-sectional; CC: case-control; NR: not reported; DM: diabetes mellitus; IL: interleukin.